Prophylaxis for acute exacerbation of interstitial pneumonia after lung resection

Asian Cardiovascular and Thoracic Annals

Volumn 22, Issue 8, 2014, Pages 948-954

  Ito, Hiroyuki ^a   Nakayama, Haruhiko ^a   Yokose, Tomoyuki ^a   Yamada, Kouzo ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Interstitiall lung diseases; lung neoplasms; postoperative complications; pulmonary fibrosis

Indexed keywords

METHYLPREDNISOLONE; SIVELESTAT; GLUCOCORTICOID; GLYCINE; SERINE PROTEINASE INHIBITOR; SULFONAMIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; BRAIN INFARCTION; BRONCHOPLEURAL FISTULA; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIABETES MELLITUS; DISEASE EXACERBATION; ECHOGRAPHY; EMPHYSEMA; FEMALE; FIBEROPTIC BRONCHOSCOPY; FIBROSING ALVEOLITIS; GENERAL ANESTHESIA; HEART INFARCTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTERSTITIAL PNEUMONIA; ISCHEMIC HEART DISEASE; LOBECTOMY; LOW DRUG DOSE; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; NON SMALL CELL LUNG CANCER; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROPHYLAXIS; PROSPECTIVE STUDY; RISK FACTOR; SPIROGRAPHY; SPUTUM CULTURE; SURGICAL MORTALITY; SURGICAL PATIENT; THORAX RADIOGRAPHY; WEDGE RESECTION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; DRUG ADMINISTRATION; IDIOPATHIC INTERSTITIAL PNEUMONIAS; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PREOPERATIVE CARE; RADIOGRAPHY; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; GLYCINE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; JAPAN; LUNG NEOPLASMS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PILOT PROJECTS; PNEUMONECTOMY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84910055521     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492314526187     Document Type: Article

References (24)

1. Koike T, Yamato Y, Asamura H, et al. Improvements in surgical results for lung cancer from 1989 to 1999 in Japan. J Thorac Oncol. 2009 ; 4: 1364-1369
2. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg. 2004 ; 78: 999-1002
3. Kudoh S, Kato H, Nishiwaki Y, et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med. 2008 ; 177: 1348-1357
4. Watanabe A, Higami T, Ohori S, et al. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?. J Thorac Cardiovasc Surg. 2008 ; 136: 1357-1363
5. Ito H, Nakayama H, Tsuboi M, et al. Subpleural honeycombing on high resolution computed tomography is risk factor for fatal pneumonitis. Ann Thorac Surg. 2011 ; 91: 874-878
6. Chida M, Ono S, Hoshikawa Y, Kondo T. Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery. Eur J Cardiothorac Surg. 2008 ; 34: 878-881
7. Tanita T, Chida M, Hoshikawa Y, et al. Experience with fatal interstitial pneumonia after operation for lung cancer. J Cardiovasc Surg. 2001 ; 42: 125-129
8. Deslauriers J, Mehran R Handbook of perioperative care in general thoracic surgery. Philadelphia: Elsevier Mosby ; 2005: 314-317.
9. Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg. 2005 ; 79: 405-410
10. Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg. 2000 ; 69: 376-380
11. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 1991 ; 177: 814-820
12. Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg. 2005 ; 80: 611-617
13. Suda K, Kitagawa Y, Ozawa S, et al. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007 ; 20: 478-486
14. Tamakuma S, Ogawa M, Aikawa N, et al. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther. 2004 ; 17: 271-279
15. Zeiher BG, Artigas A, Vincent JL, et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med. 2004 ; 32: 1695-1702
16. Jantz MA, Sahn SA. Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med. 1999 ; 160: 1079-1100
17. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988 ; 138: 62-68
18. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987 ; 317: 1565-1570
19. Rocco PR, Souza AB, Faffe DS, et al. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med. 2003 ; 168: 677-684
20. Ono S, Tsujimoto H, Hiraki S, et al. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg. 2007 ; 31: 1996-2001
21. Muraoka M, Tagawa T, Akamine S, et al. Acute interstitial pneumonia following surgery for primary lung cancer. Eur J Cardiothorac Surg. 2006 ; 30: 657-662
22. Mizuno Y, Iwata H, Shirahashi K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. Eur J Cardiothorac Surg. 2012 ; 41: e161 - e165
23. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol. 2010 ; 41: 316-325
24. Katzenstein AL. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP [Review]. Mod Pathol. 2012 ; 25: S68 - S78